TABLE 1.

Donor used for Seq-Well scRNA-seq

ID	Age	sex	HBV DNA (Log10 IU/ml)	ALT (U/L)	HBsAg (Log10 IU/ml)	HBeAg + /-	Treatment	Cell# FNA	Cell# blood
10-1003	38	M	< 20	24	2.1	Neg	+	3692	2396
10-1005	26	M	4.3	68	2.1	Neg	−	1096	1739
10-1006	51	M	< 20	29	1.7	Neg	+	491	1910
10-1007	55	M	< 20	28	2.1	Neg	+	1564	1211
20-1002	55	M	2.5	21	+	Neg	−	6247	3465
20-1003	43	M	3.8	24	+	Neg	−	1377	1063
20-3001	62	F	< 20	26	+	Neg	+	2592	1267
20-3002	42	M	< 20	10	+	Neg	+	973	601
30-1021	32	F	2.4	9	3.1	Neg	−	2074	5273
30-1022	24	F	1.4	25	2.1	Neg	−	4168	859
30-1023	29	F	3.7	40	3.8	Neg	−	3430	2602
30-1024	19	F	3.2	23	3.6	Neg	−	5012	1655
30-1025	29	M	2.8	33	2.4	Neg	−	444	774
22-0002	61	F	N/A	17	N/A	N/A	N/A	2592	2009
22-0004	64	M	N/A	18	N/A	N/A	N/A	1809	1864
22-0010	66	M	N/A	24	N/A	N/A	N/A	18	1680

Notes: + indicates qualitative HBsAg and on nucleoside analog therapy.

22-0002, 22-0004, and 22-0010 were healthy donors with no viral markers.